@TheBhupiThakur @sandeepvarma15 @ScepticalDoctor @KamathGurudutt @DrAseemMalhotra @society_eas @Drlipid @Lpa_Doc @DBelardoMD @kevinnbass @AviBittMD @The_Nutrivore it's been tested (several times). inflammation and hypercholesterolemia are independent and additive risk factors. you want neither https://t.co/Rl3mKqDY54 https://t.co/AYfQEu4QVH
Inflammatory and Cholesterol Risk in the FOURIER Trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Dec 2020 – Apr 2024Where it's discussed
-
X / Twitter17 posts
-
Facebook6 posts
-
News3 articles
-
YouTube2 videos
AI synopsis
What people are saying
Discussions demonstrate moderate engagement by referencing the study's core message, with several posts confirming that LDL lowering reduces CVD risk even in low-inflammatory environments. The tone mixes recognition of the study's importance with some debate on causal factors, reflecting both curiosity and respect for the findings.
Most discussions acknowledge the findings of the publication, with some emphasizing that LDL lowering reduces CVD risk regardless of inflammation levels.
Participants show moderate interest, discussing the relationship between LDL and inflammation, but without deeply exploring methodological details.
Posts include mentions of specific points like treatment effects and causal factors, indicating thoughtful participation without extensive analysis.
The conversations suggest an awareness of the study’s significance, especially regarding the role of LDL independent of inflammation in cardiovascular risk.
Top posts
Most liked on X and Bluesky7/8 Lastly (before you speculate that inflammation is biasing in non-carnivore populations), the relationship between LDL and CHD persists even when inflammation has been optimized. Not sure if you'd play this particular move. I'm just covering bases. https://t.co/zDV3twqeh2 https://t.co/pAjvPHbezf
@MigraineBook @professionaldog @ScepticalDoctor They're both causal. https://t.co/zDV3twHhj2 https://t.co/Z9T5VjZQh2
Inflammatory and Cholesterol Risk in the FOURIER Trial (2018)
@ChristofferBN thanks. not sure why, link seems correct: https://t.co/AYfQEu4QVH
@holmanm Why do treatments that lower LDL (and not change inflammation as measured by hsCRP) reduce risk of CVD even in low inflammation contexts? https://t.co/D7tD5WX2ua https://t.co/5sxRM44QLs https://t.co/R4K4RauPWt https://t.co/D7tD5WX2ua
All mentions
Evaluating Cholesterol Myths and Bempedoic Acid Benefits
In this video, Dr. Sten Ekberg's cholesterol claims are critically analyzed against scientific evidence. Bempedoic acid, an ATP citrate lyase inhibitor, effectively reduces LDL cholesterol with fewer side effects…
Role of Inflammation in Heart Disease and Plaque Development
What role does inflammation play in heart disease plaque growth and risk of heart attacks? If we keep inflammation in check, is that enough to reduce our heart disease risk? This video explores how inflammation…
@BroChillerman @NutritionMadeS3 Treatments that lower LDL (and do not change inflammation as measured by hsCRP) reduce risk of CVD even in low inflammation contexts. https://t.co/REGc9ytEOO
@raphaels7 @MohammedAlo Certain. https://t.co/OsGR0DAewx https://t.co/a9ZyXBA7eF https://t.co/O8PiKT1X9r https://t.co/6CxLTEzb9i https://t.co/cfUuFGzhB8 https://t.co/nm90OIZeW0 https://t.co/oHxc2peore https://t.co/zgRQjcg6W8 https://t.co/F36EVMjfL8 https://t.co/Ot9sKnnn0q
@ChristofferBN thanks. not sure why, link seems correct: https://t.co/AYfQEu4QVH
RT @agingdoc1: Inflammatory and Cholesterol Risk in the FOURIER Trial (2018)
RT @agingdoc1: Inflammatory and Cholesterol Risk in the FOURIER Trial (2018)
Inflammatory and Cholesterol Risk in the FOURIER Trial (2018)
7/8 Lastly (before you speculate that inflammation is biasing in non-carnivore populations), the relationship between LDL and CHD persists even when inflammation has been optimized. Not sure if you'd play this particular move. I'm just covering bases. https://t.co/zDV3twqeh2 https://t.co/pAjvPHbezf
@holmanm Why do treatments that lower LDL (and not change inflammation as measured by hsCRP) reduce risk of CVD even in low inflammation contexts? https://t.co/D7tD5WX2ua https://t.co/5sxRM44QLs https://t.co/R4K4RauPWt https://t.co/D7tD5WX2ua
@LDLSkeptic @ethanjweiss @ZKForTre @deirdre_tobias @realDaveFeldman You're also incorrect about the CVD benefits of other medications being explained by anti-inflammatory pleiotropic effects. Inflammation and LDL both appear to be mediators. However, I'd argue that LDL is still moderating with inflammation anyway. https://t.co/zDV3twqeh2 https://t.co/NIQwv1Nab5
@MigraineBook @professionaldog @ScepticalDoctor They're both causal. https://t.co/zDV3twHhj2 https://t.co/Z9T5VjZQh2
RT @NutritionMadeS3: @TheBhupiThakur @sandeepvarma15 @ScepticalDoctor @KamathGurudutt @DrAseemMalhotra @society_eas @Drlipid @Lpa_Doc @DBel…
RT @NutritionMadeS3: @TheBhupiThakur @sandeepvarma15 @ScepticalDoctor @KamathGurudutt @DrAseemMalhotra @society_eas @Drlipid @Lpa_Doc @DBel…
RT @NutritionMadeS3: @The_Nutrivore probably both causal factors, effect of LDL NOT explained by inflammation https://t.co/AYfQEu4QVH
RT @NutritionMadeS3: @TheBhupiThakur @sandeepvarma15 @ScepticalDoctor @KamathGurudutt @DrAseemMalhotra @society_eas @Drlipid @Lpa_Doc @DBel…
RT @NutritionMadeS3: @TheBhupiThakur @sandeepvarma15 @ScepticalDoctor @KamathGurudutt @DrAseemMalhotra @society_eas @Drlipid @Lpa_Doc @DBel…
RT @NutritionMadeS3: @TheBhupiThakur @sandeepvarma15 @ScepticalDoctor @KamathGurudutt @DrAseemMalhotra @society_eas @Drlipid @Lpa_Doc @DBel…
@TheBhupiThakur @sandeepvarma15 @ScepticalDoctor @KamathGurudutt @DrAseemMalhotra @society_eas @Drlipid @Lpa_Doc @DBelardoMD @kevinnbass @AviBittMD @The_Nutrivore it's been tested (several times). inflammation and hypercholesterolemia are independent and additive risk factors. you want neither https://t.co/Rl3mKqDY54 https://t.co/AYfQEu4QVH
GP
N
A
TM
J
CN
JH
AL
BT